GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.300 $0.440 Thursday, 18th Apr 2024 GLMD stock ended at $0.379. This is 2.80% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.89% from a day low at $0.365 to a day high of $0.379.
90 days $0.300 $0.466
52 weeks $0.260 $5.63

Historical Galmed Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
2020-10-23 $3.37 $3.37 $3.25 $3.32 19 102
2020-10-22 $3.18 $3.36 $3.18 $3.34 42 255
2020-10-21 $3.35 $3.35 $3.16 $3.20 58 854
2020-10-20 $3.33 $3.41 $3.25 $3.28 33 448
2020-10-19 $3.28 $3.37 $3.28 $3.32 25 640
2020-10-16 $3.26 $3.36 $3.19 $3.22 131 667
2020-10-15 $3.30 $3.32 $3.20 $3.20 77 637
2020-10-14 $3.41 $3.43 $3.30 $3.35 111 182
2020-10-13 $3.47 $3.53 $3.42 $3.43 47 680
2020-10-12 $3.60 $3.72 $3.43 $3.44 86 230
2020-10-09 $3.70 $3.70 $3.55 $3.55 45 467
2020-10-08 $3.75 $3.85 $3.50 $3.53 107 493
2020-10-07 $3.44 $3.74 $3.40 $3.69 130 113
2020-10-06 $3.64 $3.64 $3.28 $3.36 93 183
2020-10-05 $3.63 $3.69 $3.55 $3.58 69 421
2020-10-02 $3.55 $3.62 $3.49 $3.61 30 366
2020-10-01 $3.59 $3.62 $3.51 $3.57 51 799
2020-09-30 $3.50 $3.55 $3.36 $3.53 266 658
2020-09-29 $3.73 $3.73 $3.46 $3.46 68 314
2020-09-28 $3.59 $3.69 $3.52 $3.54 51 839
2020-09-25 $3.65 $3.70 $3.57 $3.58 228 006
2020-09-24 $3.86 $3.90 $3.59 $3.64 180 611
2020-09-23 $3.96 $3.96 $3.76 $3.80 34 132
2020-09-22 $3.91 $4.00 $3.81 $3.93 24 593
2020-09-21 $3.95 $4.09 $3.90 $3.93 28 883
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT